This grant proposal, """"""""IRON fMRI in animal models: improving sensitivity and spatial localization"""""""", is an R01 application in response to RFA EB-03-002, """"""""Systems & Methods for Small Animal Imaging"""""""". While functional brain mapping by BOLD fMRI is a common neuroscience technique in humans, animal models enable more effective techniques that are not yet available in humans. In particular, iron oxide contrast agents (IRON fMRI) offer remarkable improvements in fMRI sensitivity, appear to provide better spatial localization than the BOLD method, but suffer a somewhat slower temporal resolution than the BOLD method. The goal of the proposed project is to resolve the principal remaining issues concerning the application of IRON fMRI in animal models. Namely, 1) what are the relative merits and IRON and BOLD fMRI at very high magnetic fields, 2) what implications does the IRON temporal response have for rapidly modulated brain activity, and 3) does blood volume produce significantly better spatial localization than BOLD signal? Our hypotheses are 1) the IRON method will fill a critical role in high field fMRI by improving image quality without a loss of sensitivity, 2) intelligent stimulation strategies will mitigate disadvantages of the slow IRON temporal response even for rapidly stimulus modulations, and 3) the IRON method will improve spatial fMRI localization. Detection sensitivity and spatial resolution are among the most critical experimental factors for effective fMRI in small animal models. The proposed experiments address the most important remaining issues concerning IRON fMRI in animal models, and these studies are a logical step in the eventual progression of this powerful technique from pre-clinical studies to clinical utility.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB001782-04
Application #
7108536
Study Section
Special Emphasis Panel (ZRG1-EB (52))
Program Officer
Mclaughlin, Alan Charles
Project Start
2003-09-05
Project End
2008-08-31
Budget Start
2006-09-01
Budget End
2008-08-31
Support Year
4
Fiscal Year
2006
Total Cost
$373,219
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Mandeville, Joseph B; Liu, Christina H; Vanduffel, Wim et al. (2014) Data collection and analysis strategies for phMRI. Neuropharmacology 84:65-78
Mandeville, Joseph B (2012) IRON fMRI measurements of CBV and implications for BOLD signal. Neuroimage 62:1000-8
Nelissen, Koen; Jarraya, Bechir; Arsenault, John T et al. (2012) Neural correlates of the formation and retention of cocaine-induced stimulus-reward associations. Biol Psychiatry 72:422-8
Mandeville, Joseph B; Choi, Ji-Kyung; Jarraya, Bechir et al. (2011) fMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia. Neuropsychopharmacology 36:1187-98
Liu, Christina H; Greve, Doug N; Dai, Guangping et al. (2007) Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation. Neuroimage 34:1042-53
Mandeville, Joseph B; Leite, Francisca P; Marota, John J A (2007) Spin-echo MRI underestimates functional changes in microvascular cerebral blood plasma volume using exogenous contrast agent. Magn Reson Med 58:769-76
Leite, Francisca P; Mandeville, Joseph B (2006) Characterization of event-related designs using BOLD and IRON fMRI. Neuroimage 29:901-9
Mandeville, Joseph B; Jenkins, Bruce G; Chen, Yin-Ching I et al. (2004) Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn Reson Med 52:1272-81